• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项意大利调查:居家护理项目中晚期血液系统恶性肿瘤患者疼痛的流行病学、特征及转归

Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey.

作者信息

Niscola Pasquale, Cartoni Claudio, Romani Claudio, Brunetti Gregorio Antonio, D'Elia Gianna Maria, Cupelli Luca, Tendas Andrea, de Fabritiis Paolo, Mandelli Franco, Foà Robin

机构信息

Haematology Division, Tor Vergata University, Sant'Eugenio Hospital, Rome, Italy.

出版信息

Ann Hematol. 2007 Sep;86(9):671-6. doi: 10.1007/s00277-007-0296-4. Epub 2007 Apr 21.

DOI:10.1007/s00277-007-0296-4
PMID:17450359
Abstract

We report on epidemiology, features, outcome, and domiciliary management of pain in patients with advanced hematological malignancies followed by an experienced hospital-based home care (HC) team. Out of 469 patients, 244 (52%) experienced a total of 284 pain syndromes. Pain intensity was rated from mild to moderate in 31% and from moderate to severe in 69% of them. The diagnosed pain mechanisms were deep somatic in 56%, superficial somatic in 15%, visceral 14%, mixed 8%, and neuropathic in 7% of pain syndromes, respectively. Incident pain was observed in 38% of all pain syndromes. In every diagnostic group, deep somatic pain was prevalent. Moreover, 85% of visceral pain syndromes were observed in patients affected by non-Hodgkin's lymphoma (NHL). In addition, out of 284 pain syndromes, 150 (51%) were caused by bone involvement. The most frequent recognized pain provocative mechanisms were bone marrow expansions, osteolysis, lymph node enlargement, and mucositis. In our experience, an approach based on the association of causal therapies and analgesics allows optimal control of most pain syndromes. Therefore, pain is a major problem in patients affected by advanced hematological malignancies, and its management can be effective and feasible when carried out by a skilled HC team.

摘要

我们报告了由经验丰富的医院居家护理(HC)团队随访的晚期血液系统恶性肿瘤患者疼痛的流行病学、特征、结局及居家管理情况。在469例患者中,244例(52%)共出现284种疼痛综合征。其中31%的患者疼痛强度为轻度至中度,69%为中度至重度。在诊断出的疼痛机制中,56%为深部躯体性疼痛,15%为浅表躯体性疼痛,14%为内脏性疼痛,8%为混合性疼痛,7%为神经性疼痛综合征。在所有疼痛综合征中,38%观察到新发疼痛。在每个诊断组中,深部躯体性疼痛最为普遍。此外,85%的内脏性疼痛综合征见于非霍奇金淋巴瘤(NHL)患者。另外,在284种疼痛综合征中,150种(51%)由骨受累引起。最常见的公认疼痛激发机制是骨髓扩张、骨质溶解、淋巴结肿大和黏膜炎。根据我们的经验,基于因果治疗与镇痛药联合的方法可实现对大多数疼痛综合征的最佳控制。因此,疼痛是晚期血液系统恶性肿瘤患者的一个主要问题,由专业的HC团队进行管理时,疼痛管理可以有效且可行。

相似文献

1
Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey.一项意大利调查:居家护理项目中晚期血液系统恶性肿瘤患者疼痛的流行病学、特征及转归
Ann Hematol. 2007 Sep;86(9):671-6. doi: 10.1007/s00277-007-0296-4. Epub 2007 Apr 21.
2
Is pain in patients with haematological malignancies under-recognised? The results from Italian ECAD-O survey.血液系统恶性肿瘤患者的疼痛是否未得到充分认识?来自意大利ECAD - O调查的结果。
Leuk Res. 2010 Dec;34(12):e334-5. doi: 10.1016/j.leukres.2010.08.013. Epub 2010 Sep 21.
3
Pain in malignant hematology.恶性血液病的疼痛。
Expert Rev Hematol. 2011 Feb;4(1):81-93. doi: 10.1586/ehm.10.79.
4
Epidemiology and pathogenesis of incident pain-related disability in malignant hematology: an Italian survey.恶性血液学中新增疼痛相关残疾的流行病学与发病机制:一项意大利调查。
Ann Hematol. 2011 Jun;90(6):719-20. doi: 10.1007/s00277-010-1064-4. Epub 2010 Sep 9.
5
Effective pain management in hematological malignancies.
Expert Rev Hematol. 2009 Jun;2(3):219-22. doi: 10.1586/ehm.09.20.
6
A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis.一项多中心回顾性研究,确定了大量病例中布鲁氏菌病和全血细胞减少症的临床及血液学表现:血液系统恶性肿瘤,布鲁氏菌病患者全血细胞减少症的罕见病因。
Am J Hematol. 2008 Apr;83(4):334-9. doi: 10.1002/ajh.21098.
7
Multidisciplinary management of cancer pain: a longitudinal retrospective study on a cohort of end-stage cancer patients.癌症疼痛的多学科管理:一项针对晚期癌症患者队列的纵向回顾性研究。
J Pain Symptom Manage. 2006 Nov;32(5):444-52. doi: 10.1016/j.jpainsymman.2006.05.017.
8
Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experience.
Leuk Lymphoma. 2009 Mar;50(3):387-91. doi: 10.1080/10428190802714024.
9
Half of European cancer patients have moderate to severe pain: one in five patients does not receive treatment.
J Pain Palliat Care Pharmacother. 2007;21(4):51-3.
10
Epidemiology of pain in hospital haematological setting: an Italian survey.医院血液科疼痛的流行病学:一项意大利的调查。
Leuk Res. 2008 Jan;32(1):197-8. doi: 10.1016/j.leukres.2007.03.024. Epub 2007 Apr 26.

引用本文的文献

1
Adverse Hematological Effects of COVID-19 Vaccination and Pathomechanisms of Low Acquired Immunity in Patients with Hematological Malignancies.新型冠状病毒肺炎疫苗接种的不良血液学效应及血液系统恶性肿瘤患者获得性免疫低下的发病机制
Vaccines (Basel). 2023 Mar 15;11(3):662. doi: 10.3390/vaccines11030662.
2
An Overview of Current Recommendations and Options for the Management of Cancer Pain: A Comprehensive Review.癌症疼痛管理的当前建议与选择概述:一项全面综述
Oncol Ther. 2020 Dec;8(2):251-259. doi: 10.1007/s40487-020-00128-y. Epub 2020 Sep 7.
3
Differential Pain-Related Behaviors and Bone Disease in Immunocompetent Mouse Models of Myeloma.
骨髓瘤免疫活性小鼠模型中与疼痛相关的差异行为和骨病
JBMR Plus. 2019 Dec 30;4(2):e10252. doi: 10.1002/jbm4.10252. eCollection 2020 Feb.
4
Cancer Pain Assessment and Classification.癌症疼痛评估与分类
Cancers (Basel). 2019 Apr 10;11(4):510. doi: 10.3390/cancers11040510.
5
Caring for terminal patients in haematology: the urgent need of a new research agenda.血液学中终末期患者的护理:新研究议程的迫切需求。
Support Care Cancer. 2015 Jan;23(1):5-7. doi: 10.1007/s00520-014-2489-4. Epub 2014 Oct 24.
6
Motor disability, clinical complications, quality of life, and survival in patients with cancer: a plausible scenario.
Support Care Cancer. 2014 Oct;22(10):2603-4. doi: 10.1007/s00520-014-2213-4.
7
Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes.三名骨髓增生异常综合征患者在对人重组促红细胞生成素产生过度治疗反应后,未经任何治疗贫血持续缓解。
Support Care Cancer. 2013 Jul;21(7):1803-5. doi: 10.1007/s00520-013-1818-3. Epub 2013 Apr 21.
8
Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma.硼替佐米诱导多发性骨髓瘤患者神经病理性疼痛的控释羟考酮治疗。
Support Care Cancer. 2012 Oct;20(10):2621-6. doi: 10.1007/s00520-012-1511-y. Epub 2012 Jun 15.
9
Pain in blood cancers.血液癌症中的疼痛。
Indian J Palliat Care. 2011 Sep;17(3):175-83. doi: 10.4103/0973-1075.92333.
10
Anticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program.居家护理项目中血液系统恶性肿瘤管理的抗凝和抗栓治疗
Indian J Palliat Care. 2011 Jan;17(1):54-6. doi: 10.4103/0973-1075.78450.